AGP Executive Report
Last update: 11 hours agoObesity Research Agenda: The Endocrine Society’s new scientific statement urges researchers to measure success beyond weight loss, focusing on body fat biology, who responds best, long-term outcomes, and safety. Medicaid Drug Pricing: The Trump administration says all 50 states will use Most Favored Nation pricing for some Medicaid drugs, aiming to cut costs while details of deals stay murky. Pharmacy Middlemen Under Fire: Independent pharmacies in Arkansas sue Express Scripts over alleged underpayment, adding to state-level pressure on PBMs. 340B Accounting Pressure: A pharmacy solutions executive highlights how rebate timing can distort 340B financial reporting, complicating purchasing and formulary decisions. Clinical Access & Safety: A forced sale follows a New Jersey pharmacy enforcement action tied to a patient death after alleged unsafe dispensing and refusal to transfer prescriptions. Care Delivery Updates: Neptune Medical won FDA clearance for its robotic endoscopy system for colon procedures, and TMC Clark named a new chief medical officer to strengthen stroke and neurocritical care. Global Supply Strain: ART patients in Myanmar’s Kachin State face medicine shortages due to transport disruptions. Medical Debt Reality: A Commonwealth Fund survey finds medical debt is widespread even among privately insured adults.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.